Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes

Autor: Marie-Laure Sobrier, Serge Amselem, Heike Pfäffle, Cheri Deal, Charmian A. Quigley, Jurgen Klammt, John S. Parks, Ron G. Rosenfeld, Alan Zimmerman, Roland Pfäffle, Gordon B. Cutler, Marie Legendre, Marie-Pierre Luton, Christine Jones, Werner F. Blum, Christopher J. Child, Jan Lebl
Přispěvatelé: Universität Leipzig [Leipzig], Justus-Liebig-Universität Gießen = Justus Liebig University (JLU), Maladies génétiques d'expression pédiatrique [CHU Trousseau] (Inserm U933), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), CHU Trousseau [APHP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), UF de Génétique moléculaire [CHU Trousseau], Eli Lilly and Company Limited [Windlesham], Eli Lilly and Company [Bad Homburg] (ELC), Eli Lilly and Company [Indianapolis], Sydney Children's hospital, Gordon Cutler Consultancy LLC [Deltaville, VA, USA] (G2C), Université du Québec à Montréal = University of Québec in Montréal (UQAM), University Hospital Motol [Prague], Charles University [Prague] (CU), Oregon Health and Science University [Portland] (OHSU), Emory University School of Medicine, Emory University [Atlanta, GA], Couvet, Sandrine
Rok vydání: 2018
Předmět:
0301 basic medicine
Male
Receptors
Neuropeptide

Research paper
DNA Mutational Analysis
Physiology
Hypopituitarism
medicine.disease_cause
0302 clinical medicine
Receptors
Pituitary Hormone-Regulating Hormone

Prospective Studies
Mutation frequency
Child
Mutation
Human Growth Hormone
Nuclear Proteins
General Medicine
Growth hormone secretion
Phenotype
Child
Preschool

Pituitary Gland
Cohort
Medical genetics
Female
medicine.symptom
Transcription Factor Pit-1
medicine.medical_specialty
Adolescent
LIM-Homeodomain Proteins
030209 endocrinology & metabolism
[SDV.GEN.GH] Life Sciences [q-bio]/Genetics/Human genetics
Neuroendocrinology
Zinc Finger Protein Gli2
Short stature
General Biochemistry
Genetics and Molecular Biology

Growth hormone deficiency
03 medical and health sciences
Young Adult
Internal medicine
medicine
Genetics
Humans
Dwarfism
Pituitary

Genotyping
Homeodomain Proteins
business.industry
SOXB1 Transcription Factors
medicine.disease
Clinical trial
030104 developmental biology
[SDV.GEN.GH]Life Sciences [q-bio]/Genetics/Human genetics
Pituitary
business
Transcription Factors
Zdroj: EBioMedicine
EBioMedicine, 2018, 36, pp.390-400. ⟨10.1016/j.ebiom.2018.09.026⟩
ISSN: 2352-3964
Popis: Background: Pituitary development and GH secretion are orchestrated by multiple genes including GH1, GHRHR, GLI2, HESX1, LHX3, LHX4, PROP1, POU1F1, and SOX3. We aimed to assess their mutation frequency and clinical relevance in children with severe GH deficiency (GHD). Methods:The Genetics and Neuroendocrinology of Short Stature International Study (GeNeSIS) was a prospective, open-label, observational research program for pediatric patients receiving GH treatment, conducted in 30 countries between 1999 and 2015. The study included a sub-study to investigate mutations in the genes listed above. PCR products from genomic blood cell DNA were analyzed by Sanger sequencing. DNA variants were classified as pathogenic according to the recommendations of the American College of Medical Genetics and Genomics. Demographic, auxologic, and endocrine data at baseline and during GH treatment were documented and related to the genotyping results. Findings: The analysis comprised 917 patients. In 92 patients (10%) 33 mutations were found, 16 previously described and 17 novel (52%). Mutation carriers were significantly younger, shorter, and more slowly growing than non-carriers. In general, their peak values in GH stimulation tests were very low; however, in 15/77 (20%) patients with GH1, PROP1, and SOX3 mutations they were only moderately diminished (3- 6µg/L). Two patients with a GH1 mutation developed TSH deficiency and one ADH deficiency. Using logistic multi-regression analysis, significant indicators of a mutation were combined pituitary hormone deficiency, greater patient-parent height difference (SDS), low GH peak, and young age. Final height SDS gain in mutation carriers (mean±SD 3.4±1.4) was greater than in non-carriers (2.0±1.4; P
Databáze: OpenAIRE